Chapter 11. Selective Beta-Adrenergic Receptor-Blocking Agents

  1. Dr. János Fischer3,
  2. Prof. Dr. C. Robin Ganellin4
  1. Paul W. Erhardt1,
  2. Lajos Matos2

Published Online: 22 MAY 2006

DOI: 10.1002/3527608001.ch11

Book Title

Analogue-based Drug Discovery

Analogue-based Drug Discovery

Additional Information

How to Cite

Erhardt, P. W. and Matos, L. (2006) Selective Beta-Adrenergic Receptor-Blocking Agents, in Analogue-based Drug Discovery (eds J. Fischer and C. R. Ganellin), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527608001.ch11

Editor Information

  1. 3

    Gedeon Richter Ltd., P.O. Box 27, H-1475 Budapest 10, Hungary

  2. 4

    University College London, Department of Chemistry, 20 Gordon Street, London WC1H OAJ, UK

Author Information

  1. 1

    Center for Drug Design and Development, The University of Toledo, College of Pharmacy, Toledo, OH 43606–3390, USA

  2. 2

    Szent János Hospital, Department of Cardiology, Andrássy út 49, 1061 Budapest, Hungary

Publication History

  1. Published Online: 22 MAY 2006
  2. Published Print: 20 JAN 2006

ISBN Information

Print ISBN: 9783527312573

Online ISBN: 9783527608003

SEARCH

CHAPTER TOOLS

Get PDF (289K)

Keywords:

  • analogue-based drug discovery;
  • selective beta-adrenergic receptor-blocking agents;
  • beta-1 selective blockers;
  • Atenolol;
  • Betaxolol;
  • Celiprolol;
  • Nebivolol;
  • discovery;
  • synthesis;
  • clinical pharmacology;
  • structure-activity relationships

Summary

This chapter contains sections titled:

  • Introduction

  • Beta-1 Selective Blockers

    • Atenolol

      • Discovery

      • Synthesis

      • Clinical Pharmacology

    • Betaxolol

      • Discovery

      • Synthesis

      • Clinical Pharmacology

    • Celiprolol

      • Discovery

      • Synthesis

      • Clinical Pharmacology

    • Nebivolol

      • Discovery

      • Synthesis

      • Clinical Pharmacology

  • Accumulated Structure-Activity Relationships

  • Summary

Get PDF (289K)